semaglutide update What the FDA's on means for you Compounded Semaglutide & Tirzepatide 2025:

Private insurance companies and plan sponsors companies that provide prescription drug coverage to their workers spent more on drugs and devices for diabetes than for any other category of illness in 2025, according to a recent Telus Health report

Resveratrol and curcumin enhance pancreatic beta-cell function by inhibiting phosphodiesterase activity

Well assess your health history, weight loss goals, and potential risks to recommend the best option

doi: 10.1056/NEJMoa1901118 [DOI] [PubMed] [Google Scholar] 256

With the growing rates of obesity and diabetes, glucagon-like peptide-1 (GLP-1)-based therapies have emerged as powerful tools to tackle these conditions (16)

Wu L, Olverling A, Huang Z, Jansson L, Chao H, Gao X, Sjoholm A: GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats